EXTON, PA — Lungpacer Medical has appointed Kevin Kearney as Chief Commercial Officer (CCO), a strategic move aimed at bolstering the company’s growth and market position in the critical care sector. Kearney’s extensive experience spans over 20 years in commercial leadership, business development, and sales operations in the medical device and healthcare industries.
As CCO, Kearney will lead Lungpacer’s commercial strategy, focusing on scaling the AeroPace® System’s sales, marketing, business development, and customer engagement initiatives. The AeroPace® System is a cutting-edge technology designed to improve respiratory and cardiac patient care. Kearney will collaborate with the executive team to accelerate the company’s mission and reinforce its reputation as a key innovator in critical care.
“Kevin’s proven track record of leadership and success in commercial operations within the healthcare industry makes him the perfect fit to help us scale and bring our life-changing technologies to more patients worldwide,” said Doug Evans, CEO of Lungpacer Medical. “His deep expertise in building high-performance teams and executing strategic growth initiatives will be invaluable as we continue to drive innovation and impact in respiratory and cardiac patient care.”
Before joining Lungpacer, Kearney served as Vice President of Account Management Sales at Ceribell, where his leadership played a pivotal role in driving growth within neurology and critical care departments. His career highlights include spearheading go-to-market strategies, fostering partnerships, and achieving significant revenue growth for novel healthcare technologies.
“Lungpacer is at a pivotal point in its journey,” said Kearney. “The company’s commitment to developing innovative interventional therapies that free patients from mechanical ventilation while preserving diaphragm, lung, heart, and brain health, aligns with my passion for improving patient outcomes. I look forward to working with this talented team to advance our mission and expand our impact in the healthcare industry.”
Kearney’s appointment underscores Lungpacer’s focus on leveraging expertise to transform patient care and drive sustainable growth in the respiratory and cardiac care market.
Support the local news that supports Chester County. MyChesCo delivers reliable, fact-based reporting and essential community resources—free for everyone. If you value that, click here to become a patron today.